期刊文献+

甲状腺乳头状癌组织中HMGA2和ADAMTS8蛋白水平与临床病理参数及预后的关系

Relationship between HMGA2 and ADAMTS8 protein levels in papillary thyroid carcinoma tissue with clinical pathological parameters and prognosis
暂未订购
导出
摘要 目的 探讨甲状腺乳头状癌(PTC)组织中高迁移率族蛋白A2(HMGA2)和具有血小板反应蛋白基序8的解整合素和金属蛋白酶(ADAMTS8)蛋白水平与临床病理参数及预后的关系。方法 收集2018年12月~2020年12月于本院行甲状腺切除术的128例PTC病人的癌组织及癌旁组织,收集其临床病理资料。采用免疫组织化学法检测组织中HMGA2和ADAMTS8蛋白表达水平,并分析其与临床病理参数的关系;采用Kaplan-Meier曲线分析HMGA2和ADAMTS8表达与PTC病人预后的关系;多因素Cox回归分析HMGA2和ADAMTS8表达对PTC病人预后的影响。结果 PTC组织和癌旁组织中HMGA2蛋白阳性表达率分别为64.84%、32.03%,ADAMTS8蛋白阳性表达率分别为61.72%、34.38%,两组比较差异有统计学意义(P<0.001);PTC组织中HMGA2和ADAMTS8蛋白表达水平与脉管侵犯、TNM分期、淋巴结转移、分化程度有关(P<0.05);HMGA2和ADAMTS8阳性表达病人3年生存率低于阴性表达病人,差异有统计学意义(χ^(2)=4.807、4.236,P<0.05);HMGA2(HR=1.752,95%CI=1.129~2.718)和ADAMTS8(HR=1.497,95%CI=1.113~2.013)阳性表达是PTC病人死亡的危险因素(P<0.05)。结论 PTC组织中HMGA2和ADAMTS8蛋白阳性表达率较高,二者表达水平与临床病理参数及预后有关。 Objective To investigate the relationship between the levels of high mobility group protein A2(HMGA2)and a disintegrin and metalloproteinase with thrombospondin motifs 8(ADAMTS8)in papillary thyroid carcinoma(PTC)tissue with clinical pathological parameters and prognosis.Methods Cancer and adjacent tissues of 128 PTC patients who underwent thyroidectomy in our hospital from December 2018 to December 2020 were collected,and clinical and pathological characteristics of the patients were collected.Immunohistochemical staining was applied to detect the expression levels of HMGA2 and ADAMTS8 proteins in tissues,and their relationship with clinical pathological parameters was analyzed.Kaplan-Meier curve was applied to analyze the relationship between HMGA2 and ADAMTS8 expression and the prognosis of PTC patients.Multivariate Cox regression was applied to analyze the impacts of HMGA2 and ADAMTS8 expression on the prognosis of PTC patients.Results The positive expression rates of HMGA2 protein in PTC tissues and adjacent tissues were 64.84%and 32.03%,respectively,and the positive expression rates of ADAMTS8 procoprotein were 61.72%and 34.38%,respectively.There was a statistically significant difference between the two groups(P<0.001).The expression levels of HMGA2 and ADAMTS8 proteins in PTC tissue were related to vascular invasion,TNM staging,lymph node metastasis,and differentiation degree(P<0.05).The 3-year survival rate of HMGA2 and ADAMTS8 positive expression patients was lower than that of negative expression patients(χ^(2)=4.807,4.236,P<0.05).Positive expression of HMGA2(HR=1.752,95%CI=1.129~2.718)and positive expression of ADAMTS8(HR=1.497,95%CI=1.113~2.013)were risk factors for mortality in PTC patients(P<0.05).Conclusion The positive expression rates of HMGA2 and ADAMTS8 proteins are relatively high in PTC tissues,and their expression levels are related to clinical pathological parameters and prognosis,which has certain clinical value.
作者 黄超 管小青 陈志峰 刘利 朱小朝 HUANG Chao;GUAN Xiaoqing;CHEN Zhifeng;LIU Li;ZHU Xiaochao(Department of Breast Surgery,Suqian First People's Hospital,Suqian 223800,China)
出处 《临床外科杂志》 2025年第11期1170-1174,共5页 Journal of Clinical Surgery
基金 2021年度徐州医科大学附属医院发展基金项目(XYFZ2021008)。
关键词 甲状腺乳头状癌 高迁移率族蛋白2 ADAMTS8 临床病理参数 预后 thyroid papillary carcinoma high mobility group protein A2 a disintegrin and metalloproteinase with thrombospondin motifs 8 clinical pathological parameters prognosis
  • 相关文献

参考文献10

二级参考文献100

  • 1陈睿,杨欣,赵伟庆,方成,季枚.组蛋白三甲基化转移酶SETD2对肺腺癌上皮—间充质转化的影响[J].中国肿瘤,2020,0(2):140-147. 被引量:2
  • 2高丹,吴影,李丽娟,李化敏,付雪莲,郭素芬,展涛.甲状腺乳头状癌合并桥本甲状腺炎的临床特征及Galectin-3、HBME-1、CITED1、CK19蛋白表达的临床意义[J].慢性病学杂志,2022(10):1504-1507. 被引量:1
  • 3马明,马颖,马玲.miR-125a-5p靶向调控CDKN2B表达抑制肝癌细胞的增殖和转移[J].肿瘤学杂志,2020,0(2):112-116. 被引量:5
  • 4谭顺梓,黄益玲,黄利鸣.宫颈癌的耐药机制[J].生命的化学,2020,40(1):64-69. 被引量:5
  • 5American Thyroid Association (ATA) Guidelines Taskforce on Thy- roid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American thyroid association manage- ment guidelines for patients with thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2009, 19(11):1167-1214.
  • 6Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid as- sociation management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid as- sociation guidelines task force on thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2016, 26(1):1-133.
  • 7Tuttle RM, Haddad RI, Ball DW, et al. Thyroid carcinoma, version 2.2014[J]. J Natl Compr Canc Netw, 2014, 12(12):1671-1680.
  • 8Xing MZ. Molecular pathogenesis and mechanisms of thyroid can- cer[J]. Nat Rev Cancer, 2013, 13(3):184-199.
  • 9De Biase D, Gandolfi G, Ragazzi M, et al. TERT promoter mutations in papillary thyroid microcarcinomas[J]. Thyroid, 2015, 25(9):1013- 1019.
  • 10Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients[J]. World J Surg, 2010, 34(1):28-35.

共引文献459

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部